ZAWITZ DAVID (Chief Operating Officer) purchased 90.9% of their position (10K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $42.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2025ACC: 0002046750-25-000004
Officer· Chief Operating Officer
Since Dec 2024
+12.50K
Net shares
Net buyer
$42.4K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$4.24
Trade value
$42.42K
% of position
90.9%
11/25/2025
11K→21K
Total
Net shares
+10K
Net value
$42.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2025 | P · Purchase | +10K | $4.24 | $42.42K | 90.9% | 11K | 21K |
| Total | +10K | $42.42K | ||||||
Derivative Transactions1
Series C Warrant (right to buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
+2.50K
Strike price
6.315
Held after
2.50K
Exercisable
—
11/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Warrant (right to buy) Direct | Common Stock2.50K shares | 11/25/2025 | P · Purchase | +2.50K | 6.315 | — | 2.50K |